Brief: Hungary's Richter CEO Sees Pharma Revenues Growing Around 10% In 2025

Gedeon Richter

28/02/2025 08:32

Feb 28 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU:

HUNGARY RICHTER CEO SAYS ALL FOUR BUSINESS UNITS ACHIEVED DOUBLE-DIGIT SALES GROWTH IN HUF TERMS IN 2024

HUNGARY'S RICHTER CEO EXPECTS PHARMA REVENUES TO GROW AROUND 10% IN 2025

HUNGARY'S RICHTER CEO SAYS WE CAN RELY ON CARIPRAZINE LESS AND LESS, EXPECTS OTHER SEGMENTS TO GROW FASTER THAN CARIPRAZINE SALES

HUNGARY'S RICHTER CEO GABOR ORBAN EXPECTS NEUROPSYCHIATRY SEGMENT TO GROW AT 7%-8% IN 2025

Further company coverage: GDRB.BU

 (Warsaw Newsroom:)

 ((warsaw.newsroom@thomsonreuters.com; +48 22 6539700; Reuters Messaging: warsaw.newsroom.reuters.com@thomsonreuters.net))